Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.6200
-0.0200 (-3.13%)
Oct 30, 2026, 3:12 PM EDT
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 43.39 million as of October 30, 2026. It is the 33,530th most valuable company in the world and the 980th biggest in Canada. Its market cap has increased by 17.89% in one year.
Market Cap
43.39M
Enterprise Value
36.11M
Revenue
n/a
Global Rank
Country Rank
#980 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 43.39M, an increase of 210.91%. That is a compound annual growth rate of 28.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 43.39M | 28.77% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 75.61M |
| NurExone Biologic | 48.20M |
| Sharp Therapeutics | 43.26M |
| Medicenna Therapeutics | 42.46M |
| BriaCell Therapeutics | 42.11M |
| Sernova Biotherapeutics | 41.54M |
| Microbix Biosystems | 39.72M |
| MedMira | 35.09M |